CES and EGChatbot in Reducing Anxiety, Depression, Insomnia, and Mental Risk
Cranial Electrical Stimulation and Exercise Group Chatbot
1 other identifier
interventional
180
1 country
1
Brief Summary
The objective of this three-year study is to provide comprehensive care to young adults presenting with ARMS. The aim is use an exercise group (EGChat) developed by prior study and CES to decrease cognitive mental risks, improve emotional stability, enhance sleep quality, and elevate overall life satisfaction. A randomized controlled trial (RCT) design will be conducted using purposive sampling to recruit 180 young adults with ARMS from a medical center and its affiliated hospitals. Participants will be randomly assigned to one of three groups, undergoing a 16-week intervention: EGChat plus CES, EGChat without CES, or CES without EGChat groups. The study integrates the EGChat application into an online health promotion platform, coupled with CES intervention, to enhance the biological and psychological health of individuals at ARMS. The goal of this RCT study is to enhance the biological and psychological well-being of individuals with ARMS, covering exercise levels, Brain-Derived Neurotrophic Factor (BDNF) levels, health-promoting behaviors, metabolic indexes, cognitive mental risks, emotional status, sleep quality, and overall life quality. Assessments will occur at baseline (T0), 8 weeks into the intervention (T1), upon completion of the 16-week intervention (T2), and during a follow-up assessment at 3 months post-intervention (T3). The study will utilize generalized estimating equations (GEE) for mixed model repeated measures analysis to evaluate the significant influences of the intervention and interactions between study variables, utilizing group-time interaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2024
CompletedFirst Posted
Study publicly available on registry
July 10, 2024
CompletedStudy Start
First participant enrolled
September 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
July 10, 2024
July 1, 2024
2.6 years
June 23, 2024
July 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Levels of Cognitive Mental risk
Chinese Version of Schizotypal Personality Questionnaire-Brief (range from 0-114 scores) and Scale of Prodromal Symptoms (range from 0-22 scores)。Higher scores mean a higher cognitive risk.
week 0 (before interventions), weeks 8 (in the middle of 16 weeks interventions), weeks 16 (after interventions), 3 months follow-up (post intervention)
Levels of State Anxiety and Trait Anxiety
Chinese Mandarin State-Trait Anxiety Inventory Form Y (range from 40-160 scores)。Higher scores mean a higher anxiety levels.
week 0 (before interventions), weeks 8 (in the middle of 16 weeks interventions), weeks 16 (after interventions), 3 months follow-up (post intervention)
Levels of Depression
Taiwanese Depression Scale (range from 0-66 scores)。Higher scores mean a higher depression levels.
week 0 (before interventions), weeks 8 (in the middle of 16 weeks interventions), weeks 16 (after interventions), 3 months follow-up (post intervention)
Levels of Sleep Quality
Pittsburgh Sleep Quality Index (range from 0-21 scores)。Higher scores mean a worse sleep problems.
week 0 (before interventions), weeks 8 (in the middle of 16 weeks interventions), weeks 16 (after interventions), 3 months follow-up (post intervention)
Levels of Health-Promoting Lifestyle
Short Health-Promoting Lifestyle Profile checklist (range from 24-96 scores)。Higher scores mean a better health promotion lifestyle.
week 0 (before interventions), weeks 16 (after interventions), 3 months follow-up (post intervention)
Number of participants with Incidence of metabolic indicators
Metabolic and Physical Measures。Higher numbers of indicators mean a worse outcomes in metabolic health status.
week 0 (before interventions), weeks 8 (in the middle of 16 weeks interventions), weeks 16 (after interventions), 3 months follow-up (post intervention)
Levels of Quality of Life Questionnaire
World Health Organization Quality of Life Assessment (range from 28-140 scores)。Higher scores mean a better lif quality.
week 0 (before interventions), weeks 16 (after interventions), 3 months follow-up (post intervention)
Levels of Exercise
3-Month Physical Activity Checklist (self-report) and Actigraphy (Objective measure)。Higher scores mean a higher exercise levels.
week 0 (before interventions), weeks 16 (after interventions), 3 months follow-up (post intervention)
Study Arms (3)
Chatbot & CES
EXPERIMENTALExercise Chatbot intervention with Cranial Electrical Stimulation intervention
Chatbot
EXPERIMENTALExercise Chatbot intervention without Cranial Electrical Stimulation intervention
CES
EXPERIMENTALCranial Electrical Stimulation intervention without Exercise Chatbot intervention
Interventions
1. A exercise-promoting chatbot called EGChat, integrated into an established online health promotion platform. 2. Intervention of CES (Cranial Electrotherapy Stimulation) at Home
Intervention of CES (Cranial Electrotherapy Stimulation)
Eligibility Criteria
You may qualify if:
- between 18 and 65 years old
- meet the DSM-5 criteria for ARMS as assessed by psychiatrists, who serve as the Co-PI of this research
- exhibit persistent symptoms without clinically significant fluctuations
- consent to participate in the study and provide written informed consent.
You may not qualify if:
- have a DSM-5 diagnosis of intellectual disability or substance (including alcohol) use disorder
- possess a history of epilepsy, head trauma, central nervous system diseases, or frequent syncope
- are pregnant or lactating
- have an implanted neurostimulator or cardiac pacemaker
- have metal implants in the body
- non-removable cochlear implant
- are unable to adhere to the protocol (including the absence of a computer, tablet, or smartphone for use)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
China Medical University
Taichung, 40447, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wei-Fen Ma, PHD
School of Nursing
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2024
First Posted
July 10, 2024
Study Start
September 30, 2024
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
April 30, 2027
Last Updated
July 10, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share